VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Able to provide written informed consent and to    │ Able to provide written informed consent and to    │     100 │
│ comply with study procedures                       │ comply with study procedures                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Dutch speaking (Dutch as primary language)         │ Dutch speaking (Dutch as primary language)         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Currently dependent on any substance other than    │ Currently dependent on any substance other than    │     100 │
│ cannabis, alcohol or nicotine                      │ cannabis, alcohol or nicotine                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of any major internal disease (including   │ History of any major internal disease (including   │     100 │
│ diabetes, cardiovascular disease, lung disease,    │ diabetes, cardiovascular disease, lung disease,    │         │
│ liver or kidney disease)                           │ liver or kidney disease)                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ An active or any history of neurological disorder, │ An active or any history of neurological disorder, │     100 │
│ including but not limited to seizure disorder,     │ including but not limited to seizure disorder,     │         │
│ epilepsy, stroke, neurological disease, cognitive  │ epilepsy, stroke, neurological disease, cognitive  │         │
│ impairment, head trauma with prolonged loss of     │ impairment, head trauma with prolonged loss of     │         │
│ consciousness (\>10 minutes), or migraine          │ consciousness (>10 minutes), or migraine headaches │         │
│ headaches                                          │                                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ An active or a history of a psychiatric disorder   │ An active or a history of a psychiatric disorder   │     100 │
│ including, but not limited to, depression,         │ including, but not limited to, depression,         │         │
│ schizophrenia, bipolar disorder, anxiety, or other │ schizophrenia, bipolar disorder, anxiety, or other │         │
│ psychiatric disorders                              │ psychiatric disorders                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Asthma                                             │ Asthma                                             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known hypersensitivity or allergy to               │ Known hypersensitivity or allergy to               │     100 │
│ n-acetylcysteine, or receiving chronic therapy     │ n-acetylcysteine, or receiving chronic therapy     │         │
│ with medication that could interact adversely with │ with medication that could interact adversely with │         │
│ n-acetylcysteine within 30 days prior to           │ n-acetylcysteine within 30 days prior to           │         │
│ randomization (i.e., nitroglycerin, ACE inhibitors │ randomization (i.e., nitroglycerin, ACE inhibitors │         │
│ or antihypertensive drugs, anti-coagulants)        │ or antihypertensive drugs, anti-coagulants)        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Exclusion criteria for MRI: having metal in the    │ Exclusion criteria for MRI: having metal in the    │     100 │
│ body and/or having claustrophobia                  │ body and/or having claustrophobia                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current DSM-IV diagnosis of cannabis dependence,   │ Current DSM-IV diagnosis of cannabis dependence,   │      99 │
│ \>1 week detoxified and abstinent                  │ >1 week detoxified and abstinent                   │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                   │   Score │
╞═══════════════════════════════════╪═════════════════════════════════════════════════╪═════════╡
│ Must be MALE                      │ Asthma                                          │      22 │
├───────────────────────────────────┼─────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Able to provide written informed consent and to │      33 │
│                                   │ comply with study procedures                    │         │
├───────────────────────────────────┼─────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 45 Years │ Exclusion criteria for MRI: having metal in the │      33 │
│                                   │ body and/or having claustrophobia               │         │
╘═══════════════════════════════════╧═════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 83.61538461538461
OverAll Ratio: 90.3076923076923
